| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dermatitis, Atopic | 8 | 2019 | 714 | 1.84 | Why? |
| Mast Cells | 3 | 2019 | 370 | 1.78 | Why? |
| Galactose | 4 | 2019 | 201 | 1.72 | Why? |
| Immunoglobulin E | 8 | 2019 | 557 | 1.65 | Why? |
| Skin | 11 | 2019 | 2096 | 1.37 | Why? |
| Food Hypersensitivity | 5 | 2019 | 397 | 1.32 | Why? |
| Allergens | 7 | 2019 | 728 | 1.01 | Why? |
| Skin Neoplasms | 11 | 2020 | 1679 | 0.93 | Why? |
| Pityriasis Rubra Pilaris | 2 | 2019 | 26 | 0.90 | Why? |
| Dermatologists | 3 | 2020 | 435 | 0.82 | Why? |
| Hypersensitivity, Immediate | 3 | 2017 | 134 | 0.78 | Why? |
| Teichoic Acids | 1 | 2018 | 4 | 0.76 | Why? |
| Ecthyma, Contagious | 1 | 2018 | 8 | 0.75 | Why? |
| Orf virus | 1 | 2018 | 6 | 0.75 | Why? |
| Elastic Tissue | 1 | 2018 | 14 | 0.75 | Why? |
| Striae Distensae | 1 | 2018 | 7 | 0.74 | Why? |
| Staphylococcus epidermidis | 1 | 2018 | 53 | 0.72 | Why? |
| CTLA-4 Antigen | 1 | 2019 | 282 | 0.71 | Why? |
| Melanoma | 5 | 2020 | 1229 | 0.68 | Why? |
| Leg Ulcer | 1 | 2017 | 32 | 0.67 | Why? |
| Dermatitis, Allergic Contact | 2 | 2018 | 185 | 0.67 | Why? |
| Subcutaneous Fat | 1 | 2017 | 94 | 0.65 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2019 | 265 | 0.63 | Why? |
| Forests | 1 | 2017 | 132 | 0.63 | Why? |
| Immunity, Innate | 4 | 2018 | 6570 | 0.61 | Why? |
| Carcinoma, Basal Cell | 4 | 2018 | 144 | 0.61 | Why? |
| Eczema | 2 | 2018 | 227 | 0.58 | Why? |
| Staphylococcus aureus | 2 | 2018 | 844 | 0.55 | Why? |
| Mountaineering | 3 | 2018 | 20 | 0.55 | Why? |
| Insect Proteins | 3 | 2018 | 39 | 0.54 | Why? |
| Skin Diseases | 6 | 2020 | 2509 | 0.52 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.51 | Why? |
| Anaphylaxis | 6 | 2021 | 940 | 0.49 | Why? |
| Pruritus | 3 | 2019 | 215 | 0.48 | Why? |
| Urticaria | 4 | 2019 | 472 | 0.48 | Why? |
| Dendritic Cells | 2 | 2018 | 1330 | 0.47 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.46 | Why? |
| Meat | 3 | 2019 | 380 | 0.44 | Why? |
| Occupations | 1 | 2017 | 733 | 0.44 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.43 | Why? |
| Microbiota | 2 | 2018 | 1240 | 0.43 | Why? |
| Sunscreening Agents | 4 | 2018 | 63 | 0.41 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.40 | Why? |
| Psoriasis | 7 | 2018 | 1739 | 0.40 | Why? |
| Basophils | 3 | 2018 | 179 | 0.38 | Why? |
| Bee Venoms | 2 | 2018 | 43 | 0.34 | Why? |
| Toll-Like Receptor 2 | 2 | 2018 | 198 | 0.33 | Why? |
| Adaptive Immunity | 2 | 2018 | 2585 | 0.32 | Why? |
| Germany | 13 | 2021 | 9196 | 0.30 | Why? |
| Skin Tests | 4 | 2019 | 229 | 0.30 | Why? |
| Occupational Exposure | 4 | 2018 | 4742 | 0.29 | Why? |
| Autoimmune Diseases | 1 | 2019 | 1996 | 0.29 | Why? |
| Carcinoma, Squamous Cell | 3 | 2018 | 902 | 0.28 | Why? |
| Toll-Like Receptor 7 | 2 | 2017 | 402 | 0.26 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.26 | Why? |
| Dermatology | 4 | 2020 | 1999 | 0.25 | Why? |
| Drug Hypersensitivity | 2 | 2018 | 401 | 0.23 | Why? |
| Gardening | 2 | 2018 | 41 | 0.23 | Why? |
| Antineoplastic Agents, Immunological | 2 | 2020 | 830 | 0.22 | Why? |
| Bees | 2 | 2018 | 41 | 0.22 | Why? |
| Keratosis, Actinic | 2 | 2018 | 54 | 0.22 | Why? |
| Animals | 14 | 2019 | 78931 | 0.22 | Why? |
| Eczema, Dyshidrotic | 1 | 2019 | 1 | 0.21 | Why? |
| Administration, Cutaneous | 2 | 2018 | 229 | 0.21 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.21 | Why? |
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 2019 | 3 | 0.20 | Why? |
| Trichophyton | 1 | 2019 | 10 | 0.20 | Why? |
| Pancrelipase | 1 | 2018 | 2 | 0.20 | Why? |
| Pepsin A | 1 | 2018 | 20 | 0.20 | Why? |
| Tinea | 1 | 2019 | 22 | 0.20 | Why? |
| Humans | 72 | 2021 | 930598 | 0.20 | Why? |
| Biomarkers, Tumor | 2 | 2019 | 1314 | 0.19 | Why? |
| Photosensitivity Disorders | 1 | 2019 | 14 | 0.19 | Why? |
| Cathelicidins | 1 | 2018 | 16 | 0.19 | Why? |
| Pyoderma Gangrenosum | 1 | 2019 | 41 | 0.19 | Why? |
| Back | 1 | 2018 | 10 | 0.19 | Why? |
| Embryo Implantation | 1 | 2018 | 59 | 0.19 | Why? |
| Lipid Metabolism Disorders | 1 | 2018 | 6 | 0.19 | Why? |
| Symporters | 1 | 2019 | 80 | 0.19 | Why? |
| STAT6 Transcription Factor | 1 | 2018 | 28 | 0.19 | Why? |
| Lasers, Solid-State | 1 | 2019 | 56 | 0.19 | Why? |
| Wasp Venoms | 1 | 2018 | 6 | 0.19 | Why? |
| Iodine Radioisotopes | 1 | 2019 | 124 | 0.19 | Why? |
| Cefuroxime | 1 | 2018 | 17 | 0.18 | Why? |
| Borrelia Infections | 1 | 2017 | 12 | 0.18 | Why? |
| Occupational Diseases | 3 | 2018 | 2787 | 0.18 | Why? |
| Warts | 1 | 2019 | 59 | 0.18 | Why? |
| Ultraviolet Rays | 2 | 2018 | 1272 | 0.18 | Why? |
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2018 | 72 | 0.18 | Why? |
| Carcinoma, Basosquamous | 1 | 2017 | 2 | 0.18 | Why? |
| Pseudolymphoma | 1 | 2017 | 11 | 0.18 | Why? |
| Cell Degranulation | 1 | 2018 | 130 | 0.18 | Why? |
| Immunologic Factors | 1 | 2015 | 4206 | 0.18 | Why? |
| Receptors, Interleukin | 1 | 2018 | 83 | 0.18 | Why? |
| Kounis Syndrome | 1 | 2018 | 19 | 0.18 | Why? |
| Ear, External | 1 | 2017 | 19 | 0.18 | Why? |
| Hearing Disorders | 1 | 2019 | 62 | 0.18 | Why? |
| Postural Balance | 1 | 2019 | 144 | 0.18 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2018 | 109 | 0.17 | Why? |
| Transforming Growth Factor beta1 | 1 | 2019 | 204 | 0.17 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.17 | Why? |
| Tick Bites | 1 | 2017 | 34 | 0.17 | Why? |
| Physical Exertion | 1 | 1999 | 176 | 0.17 | Why? |
| Nevus, Pigmented | 1 | 2017 | 54 | 0.17 | Why? |
| Neoplasms, Second Primary | 1 | 2018 | 100 | 0.17 | Why? |
| Acrodermatitis | 1 | 2018 | 60 | 0.17 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.17 | Why? |
| Mitosis | 1 | 2017 | 43 | 0.17 | Why? |
| Dermatitis, Exfoliative | 1 | 2018 | 50 | 0.17 | Why? |
| Remission Induction | 2 | 2018 | 950 | 0.17 | Why? |
| Interleukin-12 | 1 | 2018 | 156 | 0.17 | Why? |
| Ear Diseases | 1 | 2017 | 58 | 0.17 | Why? |
| Keratinocytes | 1 | 2018 | 119 | 0.17 | Why? |
| Lichen Planus | 1 | 2018 | 60 | 0.17 | Why? |
| Ipilimumab | 1 | 2017 | 102 | 0.17 | Why? |
| Lupus Erythematosus, Cutaneous | 1 | 2018 | 104 | 0.16 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.16 | Why? |
| Skin Diseases, Vesiculobullous | 1 | 2018 | 112 | 0.16 | Why? |
| Protective Clothing | 2 | 2018 | 468 | 0.16 | Why? |
| Musculoskeletal Pain | 1 | 2018 | 108 | 0.16 | Why? |
| Sheep | 1 | 2018 | 420 | 0.16 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2018 | 159 | 0.16 | Why? |
| Veins | 1 | 2017 | 168 | 0.16 | Why? |
| B-Lymphocyte Subsets | 1 | 2018 | 372 | 0.16 | Why? |
| Interleukin-4 | 1 | 2018 | 367 | 0.16 | Why? |
| Angioedema | 1 | 2018 | 111 | 0.16 | Why? |
| Dermatitis, Contact | 1 | 2017 | 98 | 0.16 | Why? |
| Amyloidosis | 1 | 2018 | 178 | 0.16 | Why? |
| Dermatomyositis | 1 | 2019 | 193 | 0.16 | Why? |
| Acute Generalized Exanthematous Pustulosis | 1 | 2018 | 96 | 0.16 | Why? |
| Telepathology | 1 | 2017 | 115 | 0.16 | Why? |
| Staining and Labeling | 1 | 2017 | 169 | 0.15 | Why? |
| Th17 Cells | 2 | 2020 | 657 | 0.15 | Why? |
| Perioperative Period | 1 | 2017 | 276 | 0.15 | Why? |
| Nail Diseases | 1 | 2018 | 142 | 0.15 | Why? |
| Desensitization, Immunologic | 2 | 2020 | 574 | 0.15 | Why? |
| Awareness | 2 | 2018 | 529 | 0.15 | Why? |
| Chemokine CXCL10 | 1 | 2019 | 565 | 0.15 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.14 | Why? |
| Arteries | 1 | 2017 | 283 | 0.14 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.14 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.14 | Why? |
| Genetic Therapy | 1 | 2019 | 409 | 0.14 | Why? |
| Agriculture | 1 | 2018 | 367 | 0.14 | Why? |
| Prednisolone | 1 | 2018 | 443 | 0.14 | Why? |
| Edema | 1 | 2017 | 333 | 0.14 | Why? |
| Alkaloids | 1 | 2017 | 255 | 0.14 | Why? |
| Female | 33 | 2020 | 380317 | 0.14 | Why? |
| Anti-Inflammatory Agents | 3 | 2018 | 6153 | 0.14 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 497 | 0.14 | Why? |
| Mice, Knockout | 1 | 2019 | 1815 | 0.14 | Why? |
| Angiogenesis Inhibitors | 1 | 2018 | 395 | 0.13 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.13 | Why? |
| Antibodies, Monoclonal, Humanized | 4 | 2019 | 9335 | 0.13 | Why? |
| Hematoma | 1 | 2017 | 305 | 0.13 | Why? |
| Platelet Activation | 1 | 2018 | 660 | 0.13 | Why? |
| Gambling | 1 | 2017 | 183 | 0.13 | Why? |
| Dermoscopy | 1 | 2017 | 346 | 0.13 | Why? |
| Erythema | 1 | 2017 | 400 | 0.13 | Why? |
| Chemokines | 1 | 2019 | 1095 | 0.13 | Why? |
| Recombinant Fusion Proteins | 1 | 2018 | 919 | 0.13 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.12 | Why? |
| Hidradenitis Suppurativa | 1 | 2018 | 309 | 0.12 | Why? |
| Antibody Specificity | 1 | 2017 | 1328 | 0.12 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.12 | Why? |
| Middle Aged | 27 | 2020 | 270681 | 0.12 | Why? |
| Male | 34 | 2019 | 367725 | 0.12 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.12 | Why? |
| Mice | 4 | 2019 | 21357 | 0.12 | Why? |
| Dermatologic Agents | 1 | 2018 | 489 | 0.12 | Why? |
| Interleukin-8 | 1 | 2018 | 964 | 0.12 | Why? |
| Eosinophils | 1 | 2018 | 848 | 0.12 | Why? |
| Information Seeking Behavior | 1 | 2018 | 539 | 0.11 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2017 | 436 | 0.11 | Why? |
| Exanthema | 2 | 2018 | 1097 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.11 | Why? |
| Anti-Infective Agents, Local | 1 | 2018 | 520 | 0.11 | Why? |
| Patient-Centered Care | 1 | 2019 | 860 | 0.11 | Why? |
| Adult | 23 | 2019 | 244371 | 0.11 | Why? |
| Search Engine | 1 | 2018 | 628 | 0.11 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.11 | Why? |
| Dipeptidyl Peptidase 4 | 1 | 2018 | 1061 | 0.11 | Why? |
| Aged | 24 | 2019 | 215776 | 0.10 | Why? |
| Prevalence | 5 | 2019 | 25773 | 0.10 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| Behavior, Addictive | 1 | 2017 | 535 | 0.10 | Why? |
| Models, Immunological | 1 | 2015 | 727 | 0.10 | Why? |
| Immunotherapy | 2 | 2020 | 2421 | 0.10 | Why? |
| Diagnosis, Differential | 3 | 2018 | 7220 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Urban Population | 1 | 2019 | 2000 | 0.09 | Why? |
| Pilot Projects | 2 | 2017 | 5182 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Mice, Inbred C57BL | 1 | 2019 | 5542 | 0.09 | Why? |
| Personal Satisfaction | 1 | 2017 | 1243 | 0.09 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.09 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Blister | 2 | 2018 | 119 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Patient Education as Topic | 1 | 2017 | 1476 | 0.08 | Why? |
| Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
| Rural Population | 1 | 2019 | 2408 | 0.08 | Why? |
| Immunoglobulin A | 1 | 2018 | 3567 | 0.08 | Why? |
| Chronic Disease | 2 | 2019 | 5139 | 0.08 | Why? |
| Environmental Exposure | 1 | 2017 | 1558 | 0.08 | Why? |
| Smartphone | 1 | 2017 | 1840 | 0.08 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Flow Cytometry | 3 | 2018 | 2393 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.06 | Why? |
| Immunity, Humoral | 1 | 2018 | 4849 | 0.06 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.06 | Why? |
| Internet | 2 | 2018 | 6204 | 0.06 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Emergencies | 1 | 2018 | 4095 | 0.06 | Why? |
| Telemedicine | 3 | 2019 | 25032 | 0.06 | Why? |
| Substance-Related Disorders | 1 | 2017 | 2038 | 0.06 | Why? |
| Young Adult | 9 | 2018 | 93724 | 0.06 | Why? |
| Health Behavior | 2 | 2018 | 4449 | 0.06 | Why? |
| Cross-Sectional Studies | 6 | 2019 | 53120 | 0.06 | Why? |
| Child | 4 | 2019 | 70012 | 0.06 | Why? |
| Cross Reactions | 3 | 2018 | 4374 | 0.06 | Why? |
| Treatment Outcome | 5 | 2019 | 51732 | 0.06 | Why? |
| Mobile Applications | 1 | 2017 | 3032 | 0.06 | Why? |
| Dermis | 1 | 2019 | 35 | 0.05 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Basophil Degranulation Test | 1 | 2018 | 2 | 0.05 | Why? |
| Swine | 2 | 2018 | 3352 | 0.05 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.05 | Why? |
| Pruritus Ani | 1 | 2018 | 1 | 0.05 | Why? |
| Hedera | 1 | 2018 | 1 | 0.05 | Why? |
| Hearing Tests | 1 | 2019 | 76 | 0.05 | Why? |
| Hypertrophy | 1 | 2018 | 86 | 0.05 | Why? |
| Retreatment | 1 | 2019 | 186 | 0.05 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2019 | 274 | 0.05 | Why? |
| Chemokine CXCL12 | 1 | 2018 | 74 | 0.05 | Why? |
| Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 61 | 0.05 | Why? |
| Mice, Nude | 1 | 2019 | 340 | 0.05 | Why? |
| Transgenes | 1 | 2019 | 227 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Syndecan-1 | 1 | 2018 | 65 | 0.05 | Why? |
| Baculoviridae | 1 | 2018 | 132 | 0.04 | Why? |
| Anonymous Testing | 1 | 2017 | 2 | 0.04 | Why? |
| Coronary Vasospasm | 1 | 2018 | 36 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2019 | 184 | 0.04 | Why? |
| Histamine H1 Antagonists | 1 | 2018 | 79 | 0.04 | Why? |
| Sf9 Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Red Meat | 1 | 2017 | 39 | 0.04 | Why? |
| Insect Bites and Stings | 1 | 2018 | 63 | 0.04 | Why? |
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 71 | 0.04 | Why? |
| Immunochemistry | 1 | 2017 | 95 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2019 | 647 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Lymphoma, B-Cell | 1 | 2019 | 166 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.04 | Why? |
| Toll-Like Receptor 8 | 1 | 2017 | 102 | 0.04 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 130 | 0.04 | Why? |
| Gene Knockdown Techniques | 1 | 2018 | 347 | 0.04 | Why? |
| P-Selectin | 1 | 2018 | 224 | 0.04 | Why? |
| Dermatologic Surgical Procedures | 1 | 2019 | 138 | 0.04 | Why? |
| Pressure | 1 | 2018 | 289 | 0.04 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.04 | Why? |
| Anti-Allergic Agents | 1 | 2018 | 167 | 0.04 | Why? |
| Omalizumab | 1 | 2018 | 158 | 0.04 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.04 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.04 | Why? |
| Platelet Aggregation | 1 | 2018 | 318 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Common Variable Immunodeficiency | 1 | 2018 | 195 | 0.04 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.04 | Why? |
| Sunlight | 1 | 2019 | 287 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Blood Pressure Determination | 1 | 2019 | 450 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.04 | Why? |
| Plasma Cells | 1 | 2018 | 464 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2017 | 537 | 0.04 | Why? |
| Wound Healing | 1 | 2019 | 424 | 0.04 | Why? |
| Administrative Personnel | 1 | 2018 | 326 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2018 | 1036 | 0.04 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| Cattle | 1 | 1999 | 1336 | 0.03 | Why? |
| Th1 Cells | 1 | 2020 | 1228 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Health Services Research | 1 | 2019 | 756 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.03 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.03 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.03 | Why? |
| Public Health | 1 | 2019 | 16359 | 0.03 | Why? |
| Sewage | 1 | 2018 | 591 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Myalgia | 1 | 2018 | 1015 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2017 | 596 | 0.03 | Why? |
| Exercise Test | 1 | 1999 | 911 | 0.03 | Why? |
| Anesthesia, General | 1 | 2017 | 470 | 0.03 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.03 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.03 | Why? |
| Surveys and Questionnaires | 4 | 2019 | 43792 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.03 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
| User-Computer Interface | 1 | 2017 | 1068 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Motivation | 1 | 2018 | 1640 | 0.02 | Why? |
| Blood Pressure | 1 | 2019 | 2198 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Taste Disorders | 1 | 2018 | 1720 | 0.02 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Universities | 1 | 2020 | 4374 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Dyspnea | 1 | 2018 | 3847 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Serologic Tests | 1 | 2017 | 4359 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 5277 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Adaptation, Psychological | 1 | 2017 | 4996 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Social Media | 1 | 2018 | 5798 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |